Mutual learning for joint disease detection and severity prediction reveals multimodal pathogenesis for neurodegenerative disorders
BioinformaticsResearch Authors: Jin Zhang, Yixin Ji, Jinhua Liu, Wenrui Cui, Xiaohui Yao, Hongdong Li, Daoqiang Zhang, Lei Du, Alzheimer’s Disease Neuroimaging InitiativeAIIM Authors: Ronit Ganguli, Sara ElanchezhianApproved by President Reda RiffiPublication Date: 12/27/2025Comprehensive Summary
In their article, Zhang et al. explores the integration of genetic and proteomic data, neuroimaging data, and environmental data could lead to better diagnosis and predictive modeling for patients with Alzheimer’s disease. The researchers developed the semi-supervised method Pa-MACRO, which can perform representation learning, disease classification, quantitative trait, and predictive modeling. Using the ADNI dataset, Pa-MACRO consistently outperformed other baseline methods on diagnostic classification and cognitive score prediction, regardless of the imaging data processed by FreeSurfer. The Pa-MACRO model identified several variants related to AD, proteomic, and imaging phenotypes, such as hippocampal and temporal lobe atrophy, and interaction between genes, like smoking, alcohol, and stroke. The model suggests the use of hippocampal atrophy as the intermediate phenotype, linking genetic risk variants to clinical diagnosis and cognitive decline. The researchers emphasize the benefits of the Pa-MACRO approach for allowing multimodal learning interpretability and facilitating tasks with high-dimensional data and limited sample sizes within neurodegenerative disease research.
Outcomes and Implications
This research is important because Alzheimer’s Disease occurs from a combination of genetic factors, environmental factors, and biological factors, which are not captured by unimodal data analysis. Pa-MACRO improves the accuracy of diagnosis, prognosis, and important biomarkers. Pa-MACRO may prove to be very helpful in risk assessment and early detection of cognitive impairment issues, along with proper treatments due to the genetic risk factors and imaging of brain structure and functionalities. Though Pa-MACRO is currently applied to research studies and preclinical analysis, according to the researchers, if Pa-MACRO possesses strong generalizability properties, it could be used for clinical studies.
Connect medicine with AI innovation.
No spam. Only the latest AI breakthroughs, simplified and relevant to your field.